Eagle Bay Advisors LLC Lowers Stock Holdings in The Cooper Companies, Inc. (NASDAQ:COO)

Eagle Bay Advisors LLC cut its stake in The Cooper Companies, Inc. (NASDAQ:COO) by 11.8% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 1,470 shares of the medical device company’s stock after selling 197 shares during the period. Eagle Bay Advisors LLC’s holdings in Cooper Companies were worth $135,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also recently bought and sold shares of COO. Fulton Bank N.A. increased its position in Cooper Companies by 3.0% in the 4th quarter. Fulton Bank N.A. now owns 3,718 shares of the medical device company’s stock valued at $342,000 after acquiring an additional 109 shares during the period. Mitchell & Pahl Private Wealth LLC boosted its stake in shares of Cooper Companies by 1.5% during the 3rd quarter. Mitchell & Pahl Private Wealth LLC now owns 7,986 shares of the medical device company’s stock worth $881,000 after acquiring an additional 117 shares in the last quarter. Commonwealth Equity Services LLC lifted its stake in Cooper Companies by 0.8% in the 2nd quarter. Commonwealth Equity Services LLC now owns 15,600 shares of the medical device company’s stock valued at $1,362,000 after buying an additional 118 shares in the last quarter. Bleakley Financial Group LLC raised its holdings in Cooper Companies by 2.1% in the 3rd quarter. Bleakley Financial Group LLC now owns 5,767 shares of the medical device company’s stock valued at $636,000 after acquiring an additional 119 shares during the last quarter. Finally, Empirical Finance LLC raised its holdings in Cooper Companies by 2.2% in the 3rd quarter. Empirical Finance LLC now owns 6,786 shares of the medical device company’s stock valued at $749,000 after acquiring an additional 145 shares during the last quarter. 24.39% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

A number of brokerages recently weighed in on COO. Needham & Company LLC reaffirmed a “hold” rating on shares of Cooper Companies in a research report on Friday, December 6th. StockNews.com cut shares of Cooper Companies from a “buy” rating to a “hold” rating in a research report on Wednesday, December 11th. Citigroup dropped their price objective on shares of Cooper Companies from $116.00 to $115.00 and set a “buy” rating on the stock in a research note on Friday, December 6th. Morgan Stanley dropped their price target on shares of Cooper Companies from $104.00 to $102.00 and set an “equal weight” rating on the stock in a research note on Friday, December 6th. Finally, Wells Fargo & Company raised their price objective on shares of Cooper Companies from $115.00 to $118.00 and gave the company an “overweight” rating in a research note on Friday, December 6th. Four research analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company’s stock. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $117.00.

Cooper Companies Price Performance

Shares of Cooper Companies stock traded up $0.18 during midday trading on Monday, hitting $90.49. 658,545 shares of the company traded hands, compared to its average volume of 1,108,057. The Cooper Companies, Inc. has a 12 month low of $84.76 and a 12 month high of $112.38. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.12 and a current ratio of 1.91. The stock has a market cap of $18.06 billion, a price-to-earnings ratio of 46.41, a PEG ratio of 2.40 and a beta of 0.99. The firm’s fifty day moving average price is $97.84 and its 200-day moving average price is $98.91.

Cooper Companies (NASDAQ:COO) last posted its earnings results on Thursday, December 5th. The medical device company reported $1.04 earnings per share for the quarter, topping analysts’ consensus estimates of $1.00 by $0.04. The firm had revenue of $1.02 billion for the quarter, compared to analyst estimates of $1.03 billion. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The company’s revenue for the quarter was up 9.8% compared to the same quarter last year. During the same period in the previous year, the firm posted $0.87 EPS. As a group, sell-side analysts forecast that The Cooper Companies, Inc. will post 3.98 earnings per share for the current year.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.